- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +22 more
- Locations
-
- University of Alabama at Birmingham (UAB) Hospital /ID# 274793 Birmingham, Alabama, United States
- Usa Mitchell Cancer Institute /ID# 276022 Mobile, Alabama, United States
- University of California Los Angeles Medical Center /ID# 274566 Los Angeles, California, United States
- Scripps Md Anderson - Prebys Cancer Center /ID# 276891 San Diego, California, United States
Clinical trial condition
Neoadjuvant
Explore clinical trials studying Neoadjuvant. Study availability and eligibility vary by location and protocol.
9 public trials
7 recruiting studies
Neoadjuvant trial results
NCT05738694
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Cancer Hospital Chinese Academy of Medical Sciences Beijing, China
- Peking University First Hospital Beijing, China
- Sun Yat-sen University Cancer Center Guangzhou, China
- Anhui Provincial Hospital Hefei, China
NCT07385001
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +14 more
- Locations
-
- Tangdu Hospitial Xi'an, Shannxi, China
NCT05512481
- Conditions
- Acral Melanoma, Apatinib, Camrelizumab, +15 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
NCT06479460
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
- Locations
-
- Jiangsu Province Hospital Nanjing, Jiangsu, China
NCT06000917
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- WuhanHU Wuhan, Hubei, China
- Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
NCT04933669
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +9 more
- Locations
-
- The First Affiliated Hospital, College of Medicine, Zhejiang University Hangzhou, Zhejiang, China
Active, not recruiting
Pembrolizumab in Combination With Eftilagimod Alpha and Radiotherapy in Neoadjuvant Treatment of Patients With Soft Tissue Sarcoma - EFTISARC-NEO Trial
NCT06128863
- Conditions
- Immunotherapy, Neoadjuvant, Neoplasms, +5 more
- Locations
-
- Maria Sklodowska-Curie National Research Institute of Oncology Warsaw, Poland
NCT06129812
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
- Locations
-
Not specified